Most studies performed to date examined effects of gangliosides on AD-associated events including APP processing and Aβ deposition by adding one or more gangliosides exogenously or by inhibiting the first step in glycosphingolipid synthesis in cell culture systems17, 22, 23, 24. Here, APP is linked to Alzheimer disease.